Connection
Justin Honce to Treatment Outcome
This is a "connection" page, showing publications Justin Honce has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.043 |
|
|
|
-
Sakamoto MR, Honce JM, Lindquist DL, Camidge DR. Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib. Clin Lung Cancer. 2019 03; 20(2):e133-e136.
Score: 0.015
-
Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E. The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis. J Neurol Sci. 2018 07 15; 390:89-93.
Score: 0.015
-
Nagae LM, Honce JM, Nyberg E, Ojemann S, Abosch A, Drees CN. Imaging of Laser Therapy in Epilepsy. J Neuroimaging. 2017 05; 27(3):292-299.
Score: 0.014